These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26657044)

  • 1. Exploring Glycan Markers for Immunotyping and Precision-targeting of Breast Circulating Tumor Cells.
    Wang D; Liu X; Hsieh B; Bruce R; Somlo G; Huang J; Sambucetti L
    Arch Med Res; 2015 Nov; 46(8):642-50. PubMed ID: 26657044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycan Markers as Potential Immunological Targets in Circulating Tumor Cells.
    Wang D; Wu L; Liu X
    Adv Exp Med Biol; 2017; 994():275-284. PubMed ID: 28560680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbohydrate Microarrays Identify Blood Group Precursor Cryptic Epitopes as Potential Immunological Targets of Breast Cancer.
    Wang D; Tang J; Liu S; Huang J
    J Immunol Res; 2015; 2015():510810. PubMed ID: 26539555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Expression of Blood Group Precursor Antigen in Human Breast Cancer Tissue.
    Jiang Y; Wang D
    Int J Cancer Sci Ther; 2020; 2(1):. PubMed ID: 32879924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients.
    Kallergi G; Agelaki S; Papadaki MA; Nasias D; Matikas A; Mavroudis D; Georgoulias V
    Breast Cancer Res; 2015 Aug; 17(1):113. PubMed ID: 26285572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of miR-21 with Circulating Tumor Cells Markers Improve Diagnostic Specificity of Metastatic Breast Cancer.
    Yang X; Wang X; Shen H; Deng R; Xue K
    Cell Biochem Biophys; 2015 Sep; 73(1):87-91. PubMed ID: 25669446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the stage-specific embryonic antigen (SSEA)-0 tumor neoantigen.
    Wang D
    Curr Trends Immunol; 2023; 24():1-7. PubMed ID: 38699667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients.
    Bock C; Rack B; Huober J; Andergassen U; Jeschke U; Doisneau-Sixou S
    Future Oncol; 2014 Aug; 10(10):1751-65. PubMed ID: 25303055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of circulating tumor cells in metastatic breast cancer.
    Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW
    Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
    Frithiof H; Welinder C; Larsson AM; Rydén L; Aaltonen K
    J Transl Med; 2015 Apr; 13():126. PubMed ID: 25896421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer.
    Polioudaki H; Agelaki S; Chiotaki R; Politaki E; Mavroudis D; Matikas A; Georgoulias V; Theodoropoulos PA
    BMC Cancer; 2015 May; 15():399. PubMed ID: 25962645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.
    Zhang X; Hofmann S; Rack B; Harbeck N; Jeschke U; Sixou S
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
    Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
    Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
    Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.
    Wang HY; Ahn S; Kim S; Park S; Jung D; Park S; Han H; Sohn J; Kim S; Lee H
    Int J Clin Oncol; 2015 Oct; 20(5):878-90. PubMed ID: 25708591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.
    Spiliotaki M; Mavroudis D; Kapranou K; Markomanolaki H; Kallergi G; Koinis F; Kalbakis K; Georgoulias V; Agelaki S
    Breast Cancer Res; 2014 Nov; 16(6):485. PubMed ID: 25432416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts.
    Saldova R; Reuben JM; Abd Hamid UM; Rudd PM; Cristofanilli M
    Ann Oncol; 2011 May; 22(5):1113-1119. PubMed ID: 21127012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
    Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
    J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.